Beroni Group Limited (NSX:BTG) Enters into Convertible Loans
Summary
Sydney, Nov 9, 2023 AEST (ABN Newswire) - Beroni Group Limited ( ) ( ) advises that it has entered into an unsecured and interest free convertible loan agreement with a group of investors for a principal loan amount of US$410,397. The loan is convertible at US$1.00 per share (post-consolidation basis) upon listing of the Companys securities on the Nasdaq Stock Exchange or another US national securities exchange prior to the repayment date. About Beroni Group LimitedBeroni Group (NSX:BTG) (OTCMKTS:BNIGF) is an international biopharmaceutical enterprise dedicated to the innovation and commercialization of drugs and therapies to combat various global diseases such as cancer and infectious diseases. Its diversified portfolio is comprised of a US FDA approved virus diagnostic kit, an e-commerce platform for the sale of pharmaceutical products and a development pipeline targeting oncology and cell therapies. Beroni has operations in Australia, United States, China and Japan.
Classifications
AskAI Classifications
LabelsLinked Companies
